Clinical Trials Logo

Clinical Trial Summary

Objective To explore the predictive value of urine culture re-examination in identifying infectious complications associated with mini-PCNL in patients with preoperative positive urine culture who were treated with sensitive antibiotics. Methods Prospective and consecutive clinical data were collected from patients whose preoperative urine culture was positive and who underwent PCNL at the Department of Urology, the First Affiliated Hospital of Guangzhou Medical University. If patients'preoperative urine cultures were positive, they would be treated with appropriate antibiotics in accordance with the culture-antibiogram test results, and urine cultures were repeated on day 3 and day 7. Patients would undergo mini-PCNL after the treatment of sensitive antibiotics for 7 days, and the correlation between the results of urine culture on day 3 and day 7 and infectious complications related to mini-PCNL after surgery was analyzed.


Clinical Trial Description

PCNL (Percutaneous Nephrolithotomy) is the preferred treatment option for kidney stones with a diameter of ≥ 2 cm . Hemorrhage and infection are the primary complications following PCNL. Thanks to the advancements in interventional techniques, most hemorrhagic complications can be controlled with interventional treatment. In contrast, related infectious complications, such as urosepsis, are more perilous and challenging to control. Therefore, measures should be taken to prevent the occurrence of post-PCNL infectious complications, among which the most critical is the use of perioperative antibiotics. Currently, there is no consensus in the academic community regarding the strategy for the use of perioperative antibiotics in patients with positive preoperative urine cultures undergoing PCNL , and there is controversy over whether it is necessary to recheck urine culture after treatment with sensitive antibiotics . Some scholars believe that urine culture should be rechecked after antibiotic treatment and surgery should be performed only after the culture turns negative , but others argue that it is unnecessary to recheck urine culture after antibiotic treatment . Generally, since antibiotics might induce false-negative results in urine bacteria, it is recommended to discontinue antibiotics for more than 3 days before re-examining the urine culture . However, urological patients often have stone obstruction combined with urinary tract infection, and discontinuing antibiotics might lead to the recurrence of the infection. Therefore, this article mainly explores the role of re-examined urine culture after treatment with sensitive antibiotics in predicting infectious complications related to mini-PCNL post-surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06210425
Study type Observational
Source The First Affiliated Hospital of Guangzhou Medical University
Contact Yongda Liu, Ph.D
Phone 18922347906
Email 13719007083@163.com
Status Recruiting
Phase
Start date March 1, 2021
Completion date November 10, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A